247Compliance appLinks, recordings and certificates
Open
Questions? Call +1-661-336-9555 Group training quotes Get the app
ON-DEMAND Medical Devices

Preparing And Investigating Oos/Oot Results In A Regulated Environment

Learn to investigate OOS and OOT results step by step, from Phase I laboratory checks to full-scale investigations, with clear roles, solid reports and fewer pitfalls.

FormatRecorded sessionWatch any time
Length60 minutes
Danielle DeLucy Speaker Danielle DeLucy Pharmaceutical quality consultant · ASA Training and Consulting, LLC · MS
Talk to an expertAsk an expertQuestions about this topic

Overview

Missing or inadequate procedures for out-of-specification (OOS) results and failure investigations are among the most common deviations cited in FDA warning letters. This OOS and OOT investigations webinar reviews the regulatory requirements and how to meet them.

You'll follow the process from detecting an OOS result through the Phase I laboratory investigation and a Phase II full-scale investigation to concluding it, using a detailed flow chart that shows each step and its order.

The session explains the responsibilities of the analyst, supervisor and QA, how to structure an investigation report, how to handle out-of-trend (OOT) results and common pitfalls, with a review of OOS-related warning letter citations.

Why attend: Most companies have OOS procedures, but they are often inadequate or not followed. This session guides you through the full process, from detecting an OOS result to informal and formal laboratory and batch investigations, so your procedures hold up. It suits QA/QC and regulatory affairs directors, managers and specialists, and quality control laboratory staff.

What’s covered

  • Regulatory requirements for OOS investigations
  • Responsibilities of the analyst, supervisor and QA
  • Phase I: the laboratory investigation
  • Phase II: the full-scale investigation
  • Concluding an investigation and structuring the report
  • Out-of-trend investigations
  • Common pitfalls during OOS investigations
  • OOS-related citations in FDA warning letters

Who should attend

Quality Assurance/Quality Control Directors, Managers, and SpecialistsRegulatory Affairs/Regulatory Compliance Directors, Managers, and SpecialistsQuality Control Laboratory Staff

What you get

CertificateEmailed to each attendee after the session.
HandoutsSlides and checklists to reuse with your team.

About the speaker

Danielle DeLucy
Danielle DeLucy
Pharmaceutical quality consultant · ASA Training and Consulting, LLC

Danielle DeLucy, MS, is owner of ASA Training and Consulting, LLC which provides Pharmaceutical and Biologics based companies with training and quality systems assistance in order to meet Regulatory compliance. Prior to this role, Danielle has been in the industry for 15 years serving in numerous Quality Management Roles, such as the Director of Product Quality, the oversight of Sterility Assurance practices and provided QA oversight of numerous filling and packaging operations. Danielle began her QA career as a Quality Control Pharmaceutical Microbiologist at a contract laboratory where she performed various tests for their clients. In the years after, she has held positions in the Quality management arena while increasing her responsibility. She has helped to lead many Regulatory Health Inspections and was instrumental in the coaching process of her peers prior to any inspection. Currently, Danielle assists companies who are faced with warning letters, consent decrees and those wishing to improve compliance establish more robust quality systems so that the company can succeed. 
 

All webinars by Danielle DeLucy →
From$239On-demand · watch any time Enroll now